157 related articles for article (PubMed ID: 37999471)
1. In Vitro and In Silico Evaluations of the Antileishmanial Activities of New Benzimidazole-Triazole Derivatives.
Eser M; Çavuş İ
Vet Sci; 2023 Nov; 10(11):. PubMed ID: 37999471
[TBL] [Abstract][Full Text] [Related]
2. Discovery of small molecule acting as multitarget inhibitor of colorectal cancer by simultaneous blocking of the key COX-2, 5-LOX and PIM-1 kinase enzymes.
El-Miligy MMM; Al-Kubeisi AK; El-Zemity SR; Nassra RA; Abu-Serie MM; Hazzaa AA
Bioorg Chem; 2021 Oct; 115():105171. PubMed ID: 34303896
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, DFT Calculations,
Işık A; Acar Çevik U; Karayel A; Ahmad I; Patel H; Çelik İ; Gül ÜD; Bayazıt G; Bostancı HE; Koçak A; Özkay Y; Kaplancıklı ZA
ACS Omega; 2024 Apr; 9(16):18469-18479. PubMed ID: 38680334
[TBL] [Abstract][Full Text] [Related]
4. Antileishmanial potential of fused 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiols: Synthesis, biological evaluations and computational studies.
Patil SR; Asrondkar A; Patil V; Sangshetti JN; Kalam Khan FA; Damale MG; Patil RH; Bobade AS; Shinde DB
Bioorg Med Chem Lett; 2017 Aug; 27(16):3845-3850. PubMed ID: 28693910
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Antileishmanial Activity and
de Aquino TM; França PHB; Rodrigues ÉEES; Nascimento IJS; Santos-Júnior PFS; Aquino PGV; Santos MS; Queiroz AC; Araújo MV; Alexandre-Moreira MS; Rodrigues RRL; Rodrigues KAF; Freitas JD; Bricard J; Meneghetti MR; Bourguignon JJ; Schmitt M; da Silva-Júnior EF; de Araújo-Júnior JX
Med Chem; 2022; 18(2):151-169. PubMed ID: 33593264
[TBL] [
